Scottish Widows Puts Pension Money Into UK Quantum Startups

By Olivia Hart

Scottish Widows has become one of the first UK workplace pension providers to invest directly in venture growth companies, with initial allocations to four British science and technology firms: Oxford Quantum Circuits, Quantum Motion, Nyobolt and Genomics Limited. The money flows through a new vehicle, the CG Scottish Widows Growth LTAF, managed on the portfolio side by IP Group under an appointment from Aberdeen Investments.

The fund is deliberately narrow. It targets quantum computing, advanced battery technology and artificial intelligence applied to healthcare — not broad technology sector exposure. That focus rests on a stated belief that the UK can build global leaders in those specific fields. What the announcement does not say is how much money is committed, over what period, or what stake the pension fund takes in each company.

What does the deal actually change?

In principle, it connects defined-contribution workplace pension savers' long-term savings with high-growth British companies — opportunities historically reserved for institutional investors. In practice, the size of the initial commitment is undisclosed, which makes the scale of the change hard to judge.

Peter Fitzgerald, chief investment officer at Scottish Widows, framed the move in access terms. "We believe pension savers should be able to benefit from the growth and innovation taking place across the UK," Fitzgerald said.

That promise carries a familiar caveat: venture-stage quantum and battery companies can take a decade or more to produce returns, and some never do. Pension savers will bear that risk alongside the upside.

Who is running the money?

The structure has three named parties:

• Scottish Widows — the pension provider supplying capital from its workplace DC proposition.
• Aberdeen Investments — appointed to oversee the private markets solution.
• IP Group — engaged to manage the UK venture growth portfolio, covering both the initial allocations and future investments.

Nalaka De Silva, head of private markets solutions at Aberdeen Investments, argued the problem the fund addresses is capital supply, not company quality. "What competitive companies have lacked is sufficient pools of patient domestic capital to help them expand and grow," De Silva said.

He continued: "This partnership turns intent into investment; we are extremely proud to deliver one of the first active allocations by a UK DC workplace pension proposition to back British science and technology companies for the long-term benefit of pension members."

Note the wording: "one of the first," not the first. The UK private assets market is filling with similar announcements, and Aberdeen's own claim to precedence is carefully qualified.

Why these four companies?

The initial portfolio spans the fund's three stated themes rather than concentrating on one:

• Oxford Quantum Circuits and Quantum Motion — quantum computing hardware.
• Nyobolt — advanced battery technology.
• Genomics Limited — AI-enabled healthcare.

Greg Smith, chief executive at IP Group, cast the allocations as a democratization of venture returns. "We are helping create a pathway for millions of pension savers to participate in the value created by technology leaders," Smith stated.

He added: "It's fantastic that the fund's first UK investments span important areas including quantum computing, clean energy and healthcare innovation, sectors where the UK has the potential to build significant companies."

"Potential" is doing heavy lifting in that sentence. None of the four companies is named as profitable, and no revenue figures or valuations appear in the announcement.

What happens next?

Scottish Widows says it anticipates the initiative will unlock further growth and deliver long-term returns for members. No target return, fee structure or timeline is disclosed — so the claim will be testable only against results that may take years to materialize.

If the LTAF model works here, expect other UK workplace pension providers to follow with their own venture vehicles; if the initial four holdings stumble, the experiment could reinforce savers' caution about illiquid assets. Either way, the undisclosed commitment size means outsiders will have to judge the strategy by its next round of allocations.